openPR Logo

Press Releases from Ursatec GmbH (2 total)

STAQ Pharma and URSATEC cooperate on Desmopressin nasal spray replacement for ST …

Denver, USA / Tholey, Germany – December 15th, 2021 Recently, the only Desmopressin Acetate in an intranasal spray drug product was voluntarily recalled in the United States with an estimate to return to market of 2023. Hemophilia patients, and especially “von Willebrand’s” patients, were left with invasive treatment options that are less than ideal and costly. The Food and Drug Administration quickly moved to have the intranasal spray placed on the

Aero Pump, Validose and Ursatec cooperate on digital augmentation of pump-based …

Hochheim/New York/Tholey, Nov. 2, 2021. Aero Pump GmbH, Validose, Inc. and Ursatec GmbH today announced a collaboration to explore the usage of Validose´s biometrically secure intranasal medical device that optimizes drug delivery, prevents medication misuse and allows telemedicine and other digital facilitated control of the application, together with the market leading nasal spray systems from Aero Pump and Ursatec, targeting preserved and preservative-free nasal spray solutions. Marcel Botha, CEO of

Go To Page:   1 2 3 4 5 6 7 8 9 10